A Comparative Investigation of an in vitro and Clinical Test of the Bifidogenic Effect of an Infant Formula
- PMID: 21103029
- PMCID: PMC2966930
- DOI: 10.3164/jcbn.10-54
A Comparative Investigation of an in vitro and Clinical Test of the Bifidogenic Effect of an Infant Formula
Abstract
The bifidogenic effect of an infant formula supplemented with inulin and fructooligosaccharides (4.0 g/l) was examined clinically and in vitro, and compared that of mature breast milk. In a 28-day clinical study, fecal samples of 21 infants, divided into two groups: one receiving the infant formula and the other breast milk, were microbiologically and biochemically examined. In the in vitro investigation, microbiological and biochemical changes in the infant formula and breast milk induced by the action of bifidobacteria isolated from infant feces were examined. There were no significant differences in the fecal numbers of lactobacilli, total aerobes, anaerobes or yeasts and fungi. In contrast, the bifidobacteria numbers in the stools increased significantly during the study in the infants receiving the supplemented formula. The comparative in vitro test showed that the bifidogenic effect was similar for infant formula and breast milk in terms of the number of bifidobacteria. Consumption of infant formula with added inulin and fructooligosaccharides stimulated the bifidogenic effect, both clinically and in vitro. The in vitro test can quickly and objectively determine the bifidogenic effect of infant formula and indicate their quality. However, a clinical test is necessary to determine the acceptance and biological value of infant formula.
Keywords: bifidogenic effect; clinical examination; in vitro test; infant formula; inulin.
Similar articles
-
[The effect of natural probiotic inulin to the quantitative microbiological indicators of bifidogenic effect: in vitro research].Med Pregl. 2008 Mar-Apr;61(3-4):173-7. doi: 10.2298/mpns0804173s. Med Pregl. 2008. PMID: 18773695 Serbian.
-
Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants.J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):291-5. doi: 10.1097/00005176-200203000-00014. J Pediatr Gastroenterol Nutr. 2002. PMID: 11964956 Clinical Trial.
-
Safety and efficacy of inulin and oligofructose supplementation in infant formula: results from a randomized clinical trial.Clin Nutr. 2013 Dec;32(6):918-27. doi: 10.1016/j.clnu.2013.02.009. Epub 2013 Feb 26. Clin Nutr. 2013. PMID: 23498848 Clinical Trial.
-
Prebiotics in infant formulas.J Clin Gastroenterol. 2004 Jul;38(6 Suppl):S76-9. doi: 10.1097/01.mcg.0000128927.91414.93. J Clin Gastroenterol. 2004. PMID: 15220664 Review.
-
Oligosaccharides in infant formula.Br J Nutr. 2002 May;87 Suppl 2:S293-6. doi: 10.1079/BJNBJN/2002551. Br J Nutr. 2002. PMID: 12088532 Review.
Cited by
-
Dosage-Related Prebiotic Effects of Inulin in Formula-Fed Infants.Pediatr Gastroenterol Hepatol Nutr. 2019 Jan;22(1):63-71. doi: 10.5223/pghn.2019.22.1.63. Epub 2019 Jan 10. Pediatr Gastroenterol Hepatol Nutr. 2019. PMID: 30671375 Free PMC article.
References
-
- Fanaro S., Chierici R., Guerrini P., Vigi V. Intestinal microflora in early infancy: composition and development. Acta Paediatr. Suppl. 2003;91:48–55. - PubMed
-
- Tannock G.W. In: A Fresh Look at the Intestinal Microflora. Tannock G.W., editor. Norfolk: Horizon Scientific Press; 1999. pp. 5–14. Probiotics: a critical review.
-
- Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118:511–521. - PubMed
-
- Gdalevich M., Mimouni D., David M., Mimouni M. Breast-feeding and the onset of atopic dermatitis in childhood: a systematic review and meta-analysis of prospective studies. J. Am. Acad. Dermatol. 2001;45:520–527. - PubMed
-
- Pettigrew M.M., Khodaee M., Gillespie B., Schwartz K., Bobo J.K., Foxman B. Duration of breastfeeding, daycare and physician visits among infants 6 months and younger. Ann. Epidemiol. 2003;13:431–435. - PubMed